Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds

被引:434
|
作者
Lin, CW [1 ]
Tsai, FJ
Tsai, CH
Lai, CC
Wan, L
Ho, TY
Hsieh, CC
Chao, PDL
机构
[1] China Med Univ Hosp, Dept Med Genet & Med Res, Taichung 404, Taiwan
[2] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung 404, Taiwan
[3] China Med Univ Hosp, Dept Lab Med, Clin Virol Lab, Taichung 404, Taiwan
[4] China Med Univ, Inst Chinese Med Sci, Taichung 404, Taiwan
[5] China Med Univ, Inst Integrat Chinese & Western Med, Taichung 404, Taiwan
[6] China Med Univ, Dept Pharm, Taichung 404, Taiwan
关键词
SARS-coronavirus; 3C-like protease; Isatis indigotica root; phenolic compounds;
D O I
10.1016/j.antiviral.2005.07.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The 3C-like protease (3CL(pro),) of SARS-coronavirus mediates the proteolytic processing of replicase polypeptides 1 a and 1 ab into functional proteins, becoming an important target for the drug development. In this study, Isatis indigotica root extract, five major compounds of I indigotica root, and seven plant-derived phenolic compounds were tested for anti-SARS-CoV 3CL(pro) effects using cell-free and cell-based cleavage assays. Cleavage assays with the 3CL(pro) demonstrated that IC50 values were in micromolar ranges for I indigotica root extract, indigo, sinigrin, aloe emodin and hesperetin. Sinigrin (IC50: 217 mu M) was more efficient in blocking the cleavage processing of the 3CL(pro), than indigo (IC50: 752 mu M) and beta-sitosterol (IC50: 1210 mu M) in the cell-based assay. Only two phenolic compounds aloe emodin and hesperetin dose-dependently inhibited cleavage activity of the 3CL(pro), in which the IC50 was 366 mu M for aloe emodin and 8.3 mu M for hesperetin in the cell-based assay. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:36 / 42
页数:7
相关论文
共 33 条
  • [1] Inhibition of SARS Coronavirus 3C-Like Protease by Isatis indigotica Root and Plant-derived Phenolic Compounds
    Lin, Cheng-Wen
    Tsai, Fuu-Jen
    Tsai, Chang-Hai
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 : S79 - S79
  • [2] Anti-SARS coronavirus 3C-like protease effects of Rheum palmatum L. extracts
    Luo, Weisheng
    Su, Xiaojian
    Gong, Shouji
    Qin, Yongjun
    Liu, Weibing
    Li, Jia
    Yu, Haiping
    Xu, Qing
    [J]. BIOSCIENCE TRENDS, 2009, 3 (04) : 124 - 126
  • [3] Isatin compounds as noncovalent SARS coronavirus 3C-like protease inhibitors
    Zhou, Lu
    Liu, Ying
    Zhang, Weilin
    Wei, Ping
    Huang, Changkang
    Pei, Jianfeng
    Yuan, Yaxia
    Lai, Luhua
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (12) : 3440 - 3443
  • [4] Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors
    Ramajayam, R.
    Tan, Kian-Pin
    Liu, Hun-Ge
    Liang, Po-Huang
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (22) : 7849 - 7854
  • [5] QSAR modeling and pharmacoinformatics of SARS coronavirus 3C-like protease inhibitors
    Ishola, Ahmed Adebayo
    Adedirin, Oluwaseye
    Joshi, Tanuja
    Chandra, Subhash
    [J]. COMPUTERS IN BIOLOGY AND MEDICINE, 2021, 134
  • [6] Potent inhibition of feline coronaviruses with peptidyl compounds targeting coronavirus 3C-like protease
    Kim, Yunjeong
    Mandadapu, Sivakoteswara Rao
    Groutas, William C.
    Chang, Kyeong-Ok
    [J]. ANTIVIRAL RESEARCH, 2013, 97 (02) : 161 - 168
  • [7] Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris
    Thi Thanh Hanh Nguyen
    Hye-Jin Woo
    Hee-Kyoung Kang
    Van Dao Nguyen
    Young-Min Kim
    Do-Won Kim
    Sul-Ah Ahn
    Yongmei Xia
    Doman Kim
    [J]. Biotechnology Letters, 2012, 34 : 831 - 838
  • [8] Molecular cloning, expression, purification, and mass spectrometric characterization of 3C-like protease of SARS coronavirus
    Sun, HF
    Luo, HB
    Yu, CY
    Sun, T
    Chen, J
    Peng, SY
    Qin, J
    Shen, JH
    Yang, YM
    Xie, YH
    Chen, KX
    Wang, Y
    Shen, X
    Jiang, HL
    [J]. PROTEIN EXPRESSION AND PURIFICATION, 2003, 32 (02) : 302 - 308
  • [9] Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris
    Thi Thanh Hanh Nguyen
    Woo, Hye-Jin
    Kang, Hee-Kyoung
    Van Dao Nguyen
    Kim, Young-Min
    Kim, Do-Won
    Ahn, Sul-Ah
    Xia, Yongmei
    Kim, Doman
    [J]. BIOTECHNOLOGY LETTERS, 2012, 34 (05) : 831 - 838
  • [10] Evaluating the 3C-like protease activity of SARS-Coronavirus: Recommendations for standardized assays for drug discovery
    Grum-Tokars, Valerie
    Ratia, Kiira
    Begaye, Adrian
    Baker, Susan C.
    Mesecar, Andrew D.
    [J]. VIRUS RESEARCH, 2008, 133 (01) : 63 - 73